...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith prezzy

Thanks Bear, SF and Gen 361.

Wehn I first started paying attention to RVX and Zenith posts the communication from both companies was terrible...lacking in commitment, content and rigour. Then it seemed like the presentations got better and now I sense Don is falling back to his old ways without addressing key questions.

I find that frustrating and not very responsible to shareholders. I like others am hoping for detailed updates and for a forum for Don and the scientists to take questions.

I'd like to know the meaning of "stable mediastinal nodes over past 10 months". This seems perhaps the nodes did not grow or metasticise over the 10 month period. This I would think would be great news for these very sick people. And this is people just on zen3694...seems like good news.

Let's hope Don pulls up his socks and updates us before he heads off for a long summer vacation.

GLTA

Toinv

Share
New Message
Please login to post a reply